Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Steg PG, et al. Among authors: corbalan r. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475798 Free article. Clinical Trial.
[Coronary artery surgery in the first 24 hours after myocardial infarction].
Villavicencio M, Garayar B, Irarrázaval MJ, Morán S, Zalaquett R, Becker P, Maturana G, Corbalán R, Castro P, Fernández M. Villavicencio M, et al. Among authors: corbalan r. Rev Esp Cardiol. 2002 Feb;55(2):135-42. doi: 10.1016/s0300-8932(02)76573-1. Rev Esp Cardiol. 2002. PMID: 11852004 Free article. Spanish.
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.
Giraldez RR, Nicolau JC, Corbalan R, Gurfinkel EP, Juarez U, Lopez-Sendon J, Parkhomenko A, Molhoek P, Mohanavelu S, Morrow DA, Antman EM. Giraldez RR, et al. Among authors: corbalan r. Eur Heart J. 2007 Jul;28(13):1566-73. doi: 10.1093/eurheartj/ehm179. Epub 2007 Jun 11. Eur Heart J. 2007. PMID: 17562672 Clinical Trial.
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalán R, Aichner F, Steg PG; REACH Registry Investigators. Goto S, et al. Among authors: corbalan r. Am Heart J. 2008 Nov;156(5):855-63, 863.e2. doi: 10.1016/j.ahj.2008.06.029. Epub 2008 Sep 23. Am Heart J. 2008. PMID: 19061698
Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries.
Goyal A, Bhatt DL, Steg PG, Gersh BJ, Alberts MJ, Ohman EM, Corbalán R, Eagle KA, Gaxiola E, Gao R, Goto S, D'Agostino RB, Califf RM, Smith SC Jr, Wilson PW; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Goyal A, et al. Among authors: corbalan r. Circulation. 2010 Sep 21;122(12):1167-75. doi: 10.1161/CIRCULATIONAHA.109.919274. Epub 2010 Sep 7. Circulation. 2010. PMID: 20823388
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance.
Venkitachalam L, Wang K, Porath A, Corbalan R, Hirsch AT, Cohen DJ, Smith SC Jr, Ohman EM, Steg PG, Bhatt DL, Magnuson EA; REACH Registry Investigators. Venkitachalam L, et al. Among authors: corbalan r. Circulation. 2012 Apr 17;125(15):1858-69. doi: 10.1161/CIRCULATIONAHA.111.064378. Epub 2012 Apr 9. Circulation. 2012. PMID: 22492667
Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry.
Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, Gaxiola E, Albuquerque DC, Corbalán R, Ramos A, Bhatt DL, Steg PG; REACH Latin America Collaborative Group. Cantú-Brito C, et al. Among authors: corbalan r. Clin Cardiol. 2012 Aug;35(8):451-7. doi: 10.1002/clc.22005. Epub 2012 May 31. Clin Cardiol. 2012. PMID: 22653654 Free PMC article.
Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
Udell JA, Steg PG, Scirica BM, Eagle KA, Ohman EM, Goto S, Alsheikh-Ali AA, Porath A, Corbalan R, Umez-Eronini AA, Hoffman EB, Wilson PW, Bhatt DL; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Udell JA, et al. Among authors: corbalan r. Eur J Prev Cardiol. 2014 Dec;21(12):1531-40. doi: 10.1177/2047487313500541. Epub 2013 Aug 5. Eur J Prev Cardiol. 2014. PMID: 23918840
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
282 results